Arkolith/Insider Trading/CLVS/Form 4

Harding Thomas C.

See RemarksClovis Oncology, Inc. (CLVS) · full profile →Form 4 · filed Nov 3, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2K
Net Open-Market Flow
-$2K
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 2, 2022Sell(S)915$0.98$89719K
Nov 2, 2022Sell(S)63$0.98$624K
Nov 2, 2022Sell(S)788$0.98$77219K
Nov 1, 2022Option exercise(M)2K——19K
Nov 1, 2022Option exercise(M)181——4K
Nov 1, 2022Option exercise(M)2K——20K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 1, 2022Option exercise(M)181—$0907
Nov 1, 2022Option exercise(M)2K—$09K
Nov 1, 2022Option exercise(M)2K—$02K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-034896) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML